相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K-562 and U-937 cell lines induced by chelators and their iron complexes
Klas Forsbeck et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases
G. J. Kontoghiorghes et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Response to hydroxyurea in β thalassemia major and intermedia: Experience in western India
Khushnooma Y. Italia et al.
CLINICA CHIMICA ACTA (2009)
A NEW ERA IN IRON CHELATION THERAPY: THE DESIGN OF OPTIMAL, INDIVIDUALLY ADJUSTED IRON CHELATION THERAPIES FOR THE COMPLETE REMOVAL OF IRON OVERLOAD IN THALASSEMIA AND OTHER CHRONICALLY TRANSFUSED PATIENTS
George J. Kontoghiorghes
HEMOGLOBIN (2009)
Transparency and Access to Full Information for the Fatal or Serious Toxicity Risks, Low Efficacy and High Price of Deferasirox, Could Increase the Prospect of Improved Iron Chelation Therapy Worldwide
George J. Kontoghiorghes
HEMOGLOBIN (2008)
Pharmacogenomics and therapeutics of hemoglobinopathies
George P. Patrinos et al.
HEMOGLOBIN (2008)
Function of the hemochromatosis protein HFE: Lessons from animal models
Kostas Pantopoulos
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH)
Giovanna Fabio et al.
BLOOD (2007)
Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NAll and their combinations
GJ Kontoghiorghes et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Molecular factors and mechanisms affecting iron and other metal excretion or absorption in health and disease. The role of natural and synthetic chelators
GJ Kontoghiorghes et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis
G Papanikolaou et al.
NATURE GENETICS (2004)
Clinical trial of deferiprone iron chelation therapy in β-thalassaemia/haemoglobin E patients in Thailand
P Pootrakul et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases
P Nielsen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Increased duodenal DMT-1 expression and unchanged HFE mRNA levels in HFE-associated hereditary hemochromatosis and iron deficiency
V Byrnes et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis
OT Njajou et al.
NATURE GENETICS (2001)
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
C Camaschella et al.
NATURE GENETICS (2000)
分享论文
